umeclidinium 62.5 µg and vilanterol 25 µg
4889
Approved small_molecule active
Quick answer
umeclidinium 62.5 µg and vilanterol 25 µg for COPD (Chronic Obstructive Pulmonary Disease) is a Approved program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- COPD (Chronic Obstructive Pulmonary Disease)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active